Harish Dave | Chief Medical Officer
AUM Biosciences | Singapore

Harish Dave, Chief Medical Officer, AUM Biosciences

A Board certified Oncologist and Haematologist with over 30 years in basic science, academia and industry, as Principal Investigator, Institutional Research Head and Chief Medical Officer, overseeing basic and clinical research. He has been included in the conduct of over a 100 studies with a focus on haematology, oncology and transplantation as well as other areas of internal medicine. Dr Dave’s expertise also lies in due diligence for biotech, small, medium and large pharma and VC companies. He has basic science expertise in gene regulation, gene therapy and tumour immunology, clinical and academic expertise in haematology including coagulation disorders, oncology and transplantation and industry experience in haematology/oncology drug development from pre-clinical to phase IV space and in biosimilars/biobetters and immunotherapeutics. He has previously held senior management positions at Quintiles, George Washington University Medical Center and VA Medical Center in Washington, DC and NIH in Bethesda, MD. Dr Dave holds a MB, ChB from the University of Sheffield and an MBA from the TRIUM program (jointly awarded by NYU, London School of Economics and HEC).


Phar-East Day 2 @ 11:40

Overview: Targeted therapies in enabling precision medicine

  • Combination studies in Asia-latest updates
  • Deciding between targeted oncology therapies vs I-O, key considerations
  • Key actions transitioning from followers to leaders in targeted therapies
last published: 19/Feb/19 03:35 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738